Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aprameya EngineeringNSE:APRAMEYA -0.73%41 3-Year ROIIC % is 2.27 as of Mar. 2026, which is 43% below its 10-year median of 4.00. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 51.51% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Aprameya Engineering's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 2.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Aprameya Engineering's 3-Year ROIIC % or its related term are showing as below:
NSE:APRAMEYA's 3-Year ROIIC % is ranked better than 51.51% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.615
vs NSE:APRAMEYA: 2.27
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Aprameya Engineering 3-Year ROIIC % Related Terms
Aprameya Engineering 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Aprameya Engineering (NSE:APRAMEYA) has a 3-Year ROIIC % of 2.27 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aprameya Engineering and its competitors. This is 43% below median its historical median of 4.00. Over the past decade, Aprameya Engineering's 3-Year ROIIC % has ranged from 1.58 to 13.04. According to the industry distribution chart, Aprameya Engineering ranks #386 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 48.5%.
Is Aprameya Engineering's 3-Year ROIIC % too high?
Aprameya Engineering's current 3-Year ROIIC % of 2.27 is 43% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.58 to a high of 13.04. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Aprameya Engineering's value of 2.27 is 40.6% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #386 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #386 out of 796 companies for 3-Year ROIIC %. This puts Aprameya Engineering in the upper half of its industry. The industry median 3-Year ROIIC % is 1.62. Aprameya Engineering's value of 2.27 is 40.6% above this benchmark. Historically, Aprameya Engineering's own 3-Year ROIIC % has ranged from 1.58 to 13.04 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 1.62, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current 3-Year ROIIC % of 2.27 is 40.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current 3-Year ROIIC % is 2.27, which is 43% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current 3-Year ROIIC % of 2.27. The current 3-Year ROIIC % is 2.27, which is 43% below median its 10-year median of 4.00 and 40.6% above the Medical Devices & Instruments industry median of 1.62. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current 3-Year ROIIC % is 2.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score
Get the complete analysis for NSE:APRAMEYA
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 
